{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260603521165/en/Verastem-Oncology-Announces-U.S.-FDA-Fast-Track-Designation-for-VS-7375-an-Oral-and-Potential-Best-in-Class-Investigational-KRAS-G12D-ONOFF-Inhibitor-for-the-Treatment-of-KRAS-G12D-Mutated-Locally-Advanced-or-Metastatic-Non-Small-Cell-Lung-Cancer", "message": "News view counter 778176 successfully enlarged"}